Insufficient nitric oxide bioavailability: a hypothesis to explain adverse effects of red blood cell transfusion - PubMed (original) (raw)

Insufficient nitric oxide bioavailability: a hypothesis to explain adverse effects of red blood cell transfusion

John D Roback et al. Transfusion. 2011 Apr.

Abstract

While transfusion of red blood cells (RBCs) is effective at preventing morbidity and mortality in anemic patients, studies have indicated that some RBC components have functional defects ("RBC storage lesions") that may actually cause adverse events when transfused. For example, in some studies patients transfused with RBCs stored more than 14 days have had statistically worse outcomes than those receiving "fresher" RBC units. Recipient-specific factors may also contribute to the occurrence of these adverse events. Unfortunately, these events have been difficult to investigate because up to now they have existed primarily as "statistical occurrences" of increased morbidity and mortality in large data sets. There are currently no clinical or laboratory methods to detect or study them in individual transfusion recipients. We propose a unifying hypothesis, centered on insufficient nitric oxide bioavailability (INOBA), to explain the increased morbidity and mortality observed in some patients after RBC transfusion. In this model, variables associated with RBC units (storage time; 2,3-diphosphoglycerate acid concentration) and transfusion recipients (endothelial dysfunction) collectively lead to changes in nitric oxide (NO) levels in vascular beds. Under certain circumstances, these variables are "aligned" such that NO concentrations are markedly reduced, leading to vasoconstriction, decreased local blood flow, and insufficient O(2) delivery to end organs. Under these circumstances, the likelihood of morbidity and mortality escalates. If the key tenets of the INOBA hypothesis are confirmed, it may lead to improved transfusion methods including altered RBC storage and/or processing conditions, novel transfusion recipient screening methods, and improved RBC-recipient matching.

© 2011 American Association of Blood Banks.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Schematic diagram showing known changes that occur with RBC storage as well as the significant “unknown” links that that may lead from RBC storage lesions to adverse outcomes in transfusion recipients.

Figure 2

Figure 2

The INOBA hypothesis. Insufficient NO Bio-Availability (INOBA) is the common pathophysiological underpinning that ties together a number of diverse variables and manifestations associated with post-transfusion morbidity and mortality: RBC storage time (age), 2,3-DPG content, endothelial function, and post-transfusion hematocrit targets.

Similar articles

Cited by

References

    1. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358(12):1229–39. - PubMed
    1. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340(6):409–17. - PubMed
    1. [March 24, 2008];Health Care Cost and Utilization Project (HCUP) Facts and Figures, Statistics on hospital-based care in the United States, 2005, Exhibit 3.1. Most Frequent All-listed Procedures. At http://www.hcupus.ahrq.gov/reports.jsp. [cited.
    1. Hillyer CD, Blumberg N, Glynn SA, Ness PM. Transfusion recipient epidemiology and outcomes research: Possibilities for the future. Transfusion. 2008 in press. - PubMed
    1. Association Bulletin #01-4: Non-infectious serious hazards of transfusion - NiSHOTs. American Association of Blood Banks; Bethesda: [4/7/08]. Available http://aabb.org/Content/Members_Area/Association_Bulletins/ab01-4.htm. [cited.

Publication types

MeSH terms

Substances

LinkOut - more resources